Response to Inquiries. Icagen personnel (including, without limitation, licensees, sublicensees, transferees, successors and subcontractors) shall be available to discuss (whether in person or via telephone) with CFF the books and records and/or reports delivered by Icagen to CFF at such time or times as CFF may reasonably request.
Appears in 3 contracts
Sources: Research, Development and Commercialization Agreement (Avista Public Acquisition Corp. II), Research, Development and Commercialization Agreement (Avista Public Acquisition Corp. II), Research, Development and Commercialization Agreement (OmniAb, Inc.)